Comparison between Jagsonpal Pharmaceuticals Buyback 2026 and Windlas Biotech Buyback 2026.
Jagsonpal Pharmaceuticals Buyback 2026 is a Tender Offer buyback proposed to list at NSE, BSE while Windlas Biotech Buyback 2026 is a Tender Offer proposed to list at BSE, NSE.
| Jagsonpal Pharmaceuticals Ltd. | Windlas Biotech Ltd | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Logo |  |  | ||||||||||||||||||
| Type of Buyback | Tender Offer | Tender Offer | ||||||||||||||||||
| Listing At | NSE, BSE | BSE, NSE | ||||||||||||||||||
| Face Value | ₹10 per share | ₹5 per share | ||||||||||||||||||
| Buyback Price | ₹250 per share | ₹1000 per share | ||||||||||||||||||
| Issue Size | 16,00,000 shares | 4,70,000 shares | ||||||||||||||||||
| Issue Size (Amount) | ₹40.00 Crores | ₹47.00 Crores | ||||||||||||||||||
| Buyback Ratio |
Note:
|
Note:
| ||||||||||||||||||
| Registrar | MCS Share Transfer Agent Ltd. | MUFG Intime India Pvt.Ltd. | ||||||||||||||||||
| Lead Managers | Centrum Capital Ltd. | Fintellectual Corporate Advisors Pvt.Ltd. | ||||||||||||||||||
| Necessity of the buyback | The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
|
Jagsonpal Pharmaceuticals Buyback 2026 and Windlas Biotech Buyback 2026 buyback timetable. The investors should have the company's shares in their demat accounts as of the record date. Jagsonpal Pharmaceuticals Buyback 2026 Buyback record date is May 04, 2026. Windlas Biotech Buyback 2026 Buyback record date is Apr 24, 2026.
| Jagsonpal Pharmaceuticals Ltd. | Windlas Biotech Ltd | |
|---|---|---|
| Record Date | May 04, 2026 | Apr 24, 2026 |
| Offer Open Date | May 08, 2026 | Apr 30, 2026 |
| Offer Closure Date | May 14, 2026 | May 07, 2026 |
| Last date for receipt of tender forms | May 15, 2026 | May 07, 2026 |
| Finalisation of buyback | May 20, 2026 | May 13, 2026 |
| Last Date for settlment of bids | May 21, 2026 | Apr 14, 2026 |
| Last Date for extinguishment of shares | Jun 02, 2026 | May 25, 2026 |
Comparison of Jagsonpal Pharmaceuticals Buyback 2026 and Windlas Biotech Buyback 2026 financial data. The table below also includes a list of all relevant information like Stock Market Data, Compay Information, Lead Manager and Registrar.
| Jagsonpal Pharmaceuticals Ltd. | Windlas Biotech Ltd | ||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financial | Company Financials (Restated Consolidated)
| Company Financials (Restated Consolidated)
| |||||||||||||||||||||||||||||||||||||||
| Stock price at BSE | Stock price at BSE (in preceding 3 months)
| Stock price at BSE (in preceding 3 months)
| |||||||||||||||||||||||||||||||||||||||
| Stock price at NSE | Stock price at NSE (in preceding 3 months)
| Stock price at NSE (in preceding 3 months)
| |||||||||||||||||||||||||||||||||||||||
